Studies in human lung cancer cell lines demonstrated that though IDO mRNA can be constitutively expressed by lung cancer cells, higher IDO1 expression observed in patient samples could be attributed to production of the enzyme by other cells recruited in the tumor microenvironment and the peri‐tumoral area, thereby mediating its immune conditioning17. This evidence concerns the gene IDO1 and neoplasm.